“…It also participates in the WHO ADR monitoring program and offers ADR information to doctors, pharmacists, and other healthcare providers. Malaysia’s present medication safety system has limitations ( Rodzlan Hasani et al, 2019 ), namely, (1) in terms of pharmaceutical vigilance, there is a lack of understanding concerning medication safety among healthcare workers, (2) there is a lack of understanding regarding the presence, function, and purpose of national ADR reporting ( Shafie et al, 2019 ), (3) due to the lack of a national computerized database on the prescription administered, signal production is difficult, (4) inability to engage pharmaceutical companies with drug safety issues, (5) there is a lack of knowledge on genetic effects, social behaviors, pharmacological interactions, and contraindications linked with medicines, (6) only a few reports on traditional and herbal medications, which are commonly utilized, are present, (7) underreporting is a key flaw in all spontaneous reporting systems, (8) nursing personnel and customers were not involved in the ADR monitoring program, (9) the role of nongovernmental organizations (NGOs) in drug safety problems is limited, (10) the function of the media in public drug safety education is limited, (11) healthcare practitioners’ selective reporting (reporting bias), and (12) inadequate at spotting delayed ADRs. These limitations play a vital role in the success or failure of the policies related to the prevention and control of drugs in Malaysia.…”